Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12122776 Tetracyclic compounds and uses thereof

Patent 12122776 was granted and assigned to Gilead Sciences on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
May 12, 2023
0
Date of Patent
October 22, 2024
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
18316579
0
Patent Citations
‌
US Patent 11548902 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
0
‌
US Patent 11697652 Tetracyclic compounds and uses thereof
0
‌
US Patent 12024528 Bridged tricyclic carbamoylpyridone compounds and uses thereof
0
‌
US Patent 11884683 Tricyclic heterocycle compounds useful as HIV integrase inhibitors
0
‌
US Patent 9522912 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
0
‌
US Patent 10087178 Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor
0
‌
US Patent 10479801 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
0
‌
US Patent 11084832 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
0
‌
US Patent 11492352 Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative
0
Patent Inventor Names
Gregg M. Schwarzwalder
0
Lan Jiang
0
David W. Lin
0
Ezra Roberts
0
Michael L. Mitchell
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12122776
0
Patent Primary Examiner
‌
Matthew P Coughlin
0
CPC Code
‌
C07D 471/22
0

Find more entities like US Patent 12122776 Tetracyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo